John V. Umstead - Net Worth and Insider Trading
John V. Umstead Net Worth
The estimated net worth of John V. Umstead is at least $1 Million dollars as of 2026-09-10. John V. Umstead is the CFO of G1 Therapeutics Inc and owns about 187,718 shares of G1 Therapeutics Inc (GTHX) stock worth over $1 Million. Details can be seen in John V. Umstead's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John V. Umstead has not made any transactions after 2024-07-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John V. Umstead
John V. Umstead Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John V. Umstead owns 1 companies in total, including G1 Therapeutics Inc (GTHX) .
Click here to see the complete history of John V. Umstead’s form 4 insider trades.
Insider Ownership Summary of John V. Umstead
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2024-07-05 | Chief Financial Officer |
John V. Umstead Latest Holdings Summary
John V. Umstead currently owns a total of 1 stock. John V. Umstead owns 187,718 shares of G1 Therapeutics Inc (GTHX) as of July 5, 2024, with a value of $1 Million.
Latest Holdings of John V. Umstead
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2024-07-05 | 187,718 | 7.15 | 1,342,184 |
Holding Weightings of John V. Umstead
John V. Umstead Form 4 Trading Tracker
According to the SEC Form 4 filings, John V. Umstead has made a total of 4 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in G1 Therapeutics Inc is the sale of 527 shares on July 5, 2024, which brought John V. Umstead around $1,323.
Insider Trading History of John V. Umstead
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
John V. Umstead Trading Performance
John V. Umstead Ownership Network
Ownership Network List of John V. Umstead
Ownership Network Relation of John V. Umstead
John V. Umstead Owned Company Details
What does G1 Therapeutics Inc do?
Who are the key executives at G1 Therapeutics Inc?
John V. Umstead is the Chief Financial Officer of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Commercial Officer Andrew Perry , Chief Business Officer Mark Avagliano , and Chief Operating Officer Terry L Murdock .
G1 Therapeutics Inc (GTHX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.
G1 Therapeutics Inc Insider Transactions
John V. Umstead Mailing Address
Above is the net worth, insider trading, and ownership report for John V. Umstead. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, John V. Umstead's mailing address is: Research Triangle Park Nc 27709.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
